The government on Thursday launched three schemes to strengthen Micro, Small and Medium Enterprises (MSMEs) in the pharmaceutical sector. Union minister Mansukh Mandaviya noted that the schemes envisage technology upgradation, setting up of common research centres and effluent treatment plants in clusters for the pharma MSMEs. Small companies should be able to upgrade their facilities to global manufacturing standards, he said. The chemicals and fertilisers ministry rolled out the schemes under the banner of 'Strengthening Pharmaceuticals Industry' (SPI). "I believe the pharma MSME industry will greatly benefit from the schemes. The new schemes have many benefits that will go a long way in making the Indian pharmaceutical industry, Atma Nirbhar, more resilient and future-ready," Mandaviya, who heads both health as well as chemical and fertilisers ministries, said. The schemes provide for credit linked capital and interest subsidy for technology upgradation of MSME units in ...
UP is setting its sights on Rs 10 trillion in fresh investment from domestic and multinational companies at the high-ticket event
More than a quarter of India's micro, small and medium enterprises (MSMEs) lost over three per cent market share due to the Covid-19 pandemic, said Crisil Ltd on Monday.
Move will remove a major bottleneck for start-ups, MSMEs
Here are the top ten headlines on Wednesday morning
Not all companies had declared results for FY20. Turnover figures for previous year were used when FY20 numbers were unavailable
Mr Javadekar said MSMEs are the backbone of India's economy and therefore the Cabinet has made a road map for implementation of decisions for the MSME sector
In terms of number of deals, India ranked sixth globally
Listing helps such small companies gain investor confidence faster owing to more transparent filing norms